Advertisement
Advertisement
RARE
Ultragenyx Pharmaceutical Inc.
28.62
USDSponsored
+0.09
+0.32%
Jul 21, 16:00 UTC -4
Closed
Pre-Market
28.69
+0.07
+0.23%
Ultragenyx Pharmaceutical Inc. Financial Snapshot
| Market Cap | 2.83B |
| Beta | 0.25 |
| Earnings Per Share (EPS) | -5.84 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -85.54% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -1024.42% |
| Current Ratio | 2.48% |
| Free Cash Flow | -472.00M |
Trending Stocks
Advertisement